Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- A4437 ONO 4817Summary: MMP inhibitor
- A4413 PD 150606Target: CalpainsSummary: Non-peptide calpain inhibitor
- A4438 PD 166793Summary: MMP inhibitor
- A4420 PETCMSummary: Caspase-3 activator
- A4428 PK 44 phosphateSummary: DPP-IV inhibitor
- A4414 PMPA (NAALADase inhibitor)Summary: Glutamate carboxypeptidase 2 inhibitor
- A4408 SC 57461ASummary: LTA4 hydrolase inhibitor,potent and selective
- A4424 SID 26681509Target: CathepsinsSummary: Human cathepsin L inhibitor,potent and reversible
- A4430 Sivelestat sodium saltTarget: ElastasesSummary: Leukocyte elastase inhibitor
- A4409 SpinorphinSummary: P2X3 receptors against